Scinai Immunotherapeutics Ltd. (SCNI) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$1.3M

Net Income/Loss (FY2025)

-$8.3M

Total Assets (FY2025)

$11.6M

Total Equity (FY2025)

$8.1M

Cash Flows from Operating Activities (FY2025)

-$6.0M

Source: Scinai Immunotherapeutics Ltd. 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.